Ira Duarte
Directeur Financier/CFO chez HERON THERAPEUTICS, INC.
Fortune : 826 743 $ au 31/05/2024
Postes actifs de Ira Duarte
Sociétés | Poste | Début | Fin |
---|---|---|---|
TERRASCEND CORP. | Directeur/Membre du Conseil | 02/12/2022 | - |
Independent Dir/Board Member | 02/12/2022 | - | |
HERON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 29/03/2024 | - |
Directeur Financier/CFO | 16/06/2023 | - | |
Investor Relations Contact | 16/06/2023 | - | |
Public Communications Contact | 16/06/2023 | - |
Historique de carrière de Ira Duarte
Anciens postes connus de Ira Duarte
Sociétés | Poste | Début | Fin |
---|---|---|---|
VELOXIS PHARMACEUTICALS A/S | Comptroller/Controller/Auditor | 01/02/2016 | 01/01/2023 |
Directeur Financier/CFO | 24/09/2018 | 01/01/2023 | |
Public Communications Contact | - | 01/01/2023 | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Comptroller/Controller/Auditor | 01/01/2014 | 01/01/2016 |
CORNERSTONE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2009 | 01/10/2013 |
Corporate Officer/Principal | - | 01/06/2009 | |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young A/S is a consulting firm that provides analytics consulting services, assurance, tax, and transaction services to help clients solve their toughest challenges and build a better working world. The company is based in Aabyhoj, Denmark. The Danish company's analytics consulting services utilize the latest technology to integrate data and analytics throughout clients' business processes and operations. Additionally, EY Sustainability Tax professionals can help businesses realize their corporate sustainability strategy. | Corporate Officer/Principal | - | - |
Formation de Ira Duarte
Florida Atlantic University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Danemark | 3 |
Canada | 2 |
Opérationnelle
Comptroller/Controller/Auditor | 4 |
Director of Finance/CFO | 2 |
Public Communications Contact | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
TERRASCEND CORP. | Process Industries |
HERON THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young A/S is a consulting firm that provides analytics consulting services, assurance, tax, and transaction services to help clients solve their toughest challenges and build a better working world. The company is based in Aabyhoj, Denmark. The Danish company's analytics consulting services utilize the latest technology to integrate data and analytics throughout clients' business processes and operations. Additionally, EY Sustainability Tax professionals can help businesses realize their corporate sustainability strategy. | Commercial Services |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Bourse
- Insiders
- Ira Duarte
- Expérience